TibaRay's Galactica Systems Enter Manufacturing, Near Clinical Use
TibaRay's Galactica cancer treatment systems have entered manufacturing, marking a significant step towards clinical deployment. This advancement signals upcoming demand for specialized healthcare facilities and potential changes in compliance and procurement processes.